FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Positron Emission Tomography (PET)|DRUG: Fluorine-18 labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC)|PROCEDURE: Positron emission mammography (PEM) When available|PROCEDURE: MR
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: GE Healthcare